1. Pharmacokinetics and safety of multiple oral doses of sustained-release 4- aminopyridine (fampridine-sr) in subjects with chronic, incomplete spinal cord injury 1 
Keith C Hayes, PhD, Patrick J Potter, MD, Jane T Hsieh, MSc, Mitchell A Katz, PhD, Andrew R Blight, PhD, Ron Cohen, MD 
Archives of Physical Medicine and Rehabilitation 
Volume 85, Issue 1, Pages (January 2004)
DOI: /S (03)

2. Fig 1
Mean plasma concentrations by time and dosage level for the 11 subjects completing the study. Abbreviation: bid, twice daily.
Archives of Physical Medicine and Rehabilitation  , 29-34DOI: ( /S (03) )

3. Fig 2
Mean Cmax and AUC0–12 versus Fampridine-SR dosage level for the 11 subjects completing the study. Vertical bars represent ±standard deviation.
Archives of Physical Medicine and Rehabilitation  , 29-34DOI: ( /S (03) )